Journal
ANTIOXIDANTS & REDOX SIGNALING
Volume 37, Issue 7-9, Pages 560-577Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2021.0155
Keywords
fatty acids; neuropathy; diabetes; prediabetes; dyslipidemia
Funding
- National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) [1R24DK082841, 1R21NS102924, 1F32DK112642, K99/R00 DK119366]
- e American Diabetes Asso-ciation [7-12-BS-045]
- Neuro-Network for Emerging Therapies
- A. Alfred Taubman Medical Research Institute
Ask authors/readers for more resources
Peripheral neuropathy (PN) is the most prevalent complication of diabetes and prediabetes, characterized by progressive sensory loss due to nerve damage. Dyslipidemia, a component of metabolic syndrome, is strongly associated with PN in type 2 diabetes (T2D) and prediabetes. Fatty acids (FAs) have been implicated in PN pathogenesis, with saturated and unsaturated FAs showing differential effects on nerve lipid profile and function.
Significance: As the global prevalence of diabetes rises, diabetic complications are also increasing at an alarming rate. Peripheral neuropathy (PN) is the most prevalent complication of diabetes and prediabetes, and is characterized by progressive sensory loss resulting from nerve damage. While hyperglycemia is the major risk factor for PN in type 1 diabetes (T1D), the metabolic syndrome (MetS) underlies the onset and progression of PN in type 2 diabetes (T2D) and prediabetes.Recent Advances: Recent reports show that dyslipidemia, a MetS component, is strongly associated with PN in T2D and prediabetes. Dyslipidemia is characterized by an abnormal plasma lipid profile with uncontrolled lipid levels, and both clinical and preclinical studies implicate a role for dietary fatty acids (FAs) in PN pathogenesis. Molecular studies further show that saturated and unsaturated FAs differentially regulate the nerve lipid profile and nerve function.Critical Issues: We first review the properties of FAs and the neuroanatomy of the peripheral nervous system (PNS). Second, we discuss clinical and preclinical studies that implicate the involvement of FAs in PN. Third, we summarize the potential effects of FAs on nerve function and lipid metabolism within the peripheral nerves, sensory neurons, and Schwann cells.Future Directions: Future directions will focus on identifying molecular pathways in T2D and prediabetes that are modulated by FAs in PN. Determining pathophysiological mechanisms that underlie the injurious effects of saturated FAs and beneficial properties of unsaturated FAs will provide mechanistic targets for developing new targeted therapies to treat PN associated with T2D and prediabetes.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available